An exploratory study on the pathogenesis of cutaneous vasculitis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052802

Enrollment

Unknown

Registered

2021-11-05

Start date

2021-11-04

Completion date

Unknown

Last updated

2022-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cutaneous vasculitis

Interventions

Control group:No

Cutaneous vasculitis group:No

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. All types of primary cutaneous vasculitis and secondary cutaneous vasculitis include rheumatoid vasculitis (RV), lupus vasculitis, scleroderma vasculitis, and all accompanying vasculitis with thromboangiitis obliterans, arteriosclerosis obliterans, diabetic foot and other peripheral vasculitis; 2. Sign informed consent; 3. No age limit; 4. Both men and women.

Exclusion criteria

Exclusion criteria: 1. Combined with hemorrhagic disease, severe hepatorenal insufficiency, systemic infectious diseases, malignant tumors and mental disorders; 2. Severe allergic constitution; 3. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Basic clinical information;Safety index;Inflammatory factor (IL-1 beta, IL-6, IL-10, IL-17, IL-27, IL-35, TNF-beta, TGF-beta, MMP13);Rheumatism immunoassay;	—

Countries

China

Contacts

Public ContactCao Yemin

Shanghai TCM-Integrated Hospital, Shanghai University of TCM

dr-cao@163.com+86 13361831119

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026